Bone Marrow-Derived Cells as a Therapeutic Approach to Optic Nerve Diseases

Stem Cells International

Volumn 2016, Issue , 2016, Pages

  Mesentier Louro, Louise A ^a   Zaverucha Do Valle, Camila ^b   Rosado De Castro, Paulo H ^a   Silva, Almir J ^a   Pimentel Coelho, Pedro M ^a   Mendez Otero, Rosalia ^a   Santiago, Marcelo F ^a  

^a FEDERAL UNIVERSITY OF RIO DE JANEIRO   (Brazil)

^b Funda??o Oswaldo Cruz   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

PADGEM PROTEIN; PLATELET DERIVED GROWTH FACTOR; PLATELET DERIVED GROWTH FACTOR AA; PLATELET DERIVED GROWTH FACTOR AB;

APOPTOSIS; BONE MARROW CELL; BONE MARROW DERIVED MESENCHYMAL STEM CELL; BONE MARROW DERIVED MONONUCLEAR CELL; CELL DIFFERENTIATION; CELL PROLIFERATION; CELL SURVIVAL; ENDOPLASMIC RETICULUM STRESS; GLAUCOMA; IMMUNOGENICITY; INTRAOCULAR PRESSURE; NERVE CELL PLASTICITY; NEUROPROTECTION; NONHUMAN; OPTIC NERVE DISEASE; PRIORITY JOURNAL; RETINA GANGLION CELL; REVIEW; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY;

EID: 84948845409     PISSN: None     EISSN: 16879678     Source Type: Journal    
DOI: 10.1155/2016/5078619     Document Type: Review

References (142)

1. A. Ghaffarieh and L. A. Levin, "Optic nerve disease and axon pathophysiology," International Review of Neurobiology, vol. 105, pp. 1-17, 2012.
2. I. Soto and G. R. Howell, "The complex role of neuroinflammation in glaucoma," Cold Spring Harbor Perspectives in Medicine, vol. 4, no. 8, 2014.
3. Y.-C. Tham, X. Li, T. Y. Wong, H. A. Quigley, T. Aung, and C.-Y. Cheng, "Global prevalence of glaucoma and projections of glaucoma burden through 2040: a systematic review and metaanalysis," Ophthalmology, vol. 121, no. 11, pp. 2081-2090, 2014.
4. M. Almasieh, A.M. Wilson, B. Morquette, J. L. Cueva Vargas, and A. Di Polo, "The molecular basis of retinal ganglion cell death in glaucoma," Progress in Retinal and Eye Research, vol. 31, no. 2, pp. 152-181, 2012.
5. R. N. Weinreb, T. Aung, and F. A. Medeiros, "The pathophysiology and treatment of glaucoma: a review," The Journal of the American Medical Association, vol. 311, no. 18, pp. 1901-1911, 2014.
6. R. Behbehani, "Clinical approach to optic neuropathies," linical Ophthalmology, vol. 1, no. 3, pp. 233-246, 2007.
7. D. P. Dworak and J. Nichols, "A review of optic neuropathies," Disease-a-Month, vol. 60, no. 6, pp. 276-281, 2014.
8. V. Carelli, C. LaMorgia, M. L. Valentino, P. Barboni, F. N. Ross-Cisneros, and A. A. Sadun, "Retinal ganglion cell neurodegeneration in mitochondrial inherited disorders," Biochimica et Biophysica Acta-Bioenergetics, vol. 1787, no. 5, pp. 518-528, 2009.
9. C. La Morgia, M. Carbonelli, P. Barboni, A. A. Sadun, and V. Carelli, "Medical management of hereditary optic neuropathies," Frontiers in Neurology, vol. 5, article 141, 2014.
10. B. Mascialino, M. Leinonen, and T. Meier, "Meta-analysis of the prevalence of Leber hereditary optic neuropathy mtDNA mutations in Europe," European Journal of Ophthalmology, vol. 22, no. 3, pp. 461-465, 2012.
11. P. Yu-Wai-Man and P. F. Chinnery, "Dominant optic atrophy: novel OPA1 mutations and revised prevalence estimates," Ophthalmology, vol. 120, no. 8, p. 1712.e1, 2013.
12. H. V. Danesh-Meyer, H. Birch, J. Y.-F. Ku, S. Carroll, and G. Gamble, "Reduction of optic nerve fibers in patients with Alzheimer disease identified by laser imaging," Neurology, vol. 67, no. 10, pp. 1852-1854, 2006.
13. A. London, I. Benhar, and M. Schwartz, "Theretina as awindow to the brain-from eye research to CNS disorders," Nature Reviews Neurology, vol. 9, no. 1, pp. 44-53, 2013.
14. M. E. Schwab, J. P. Kapfhammer, and C. E. Bandtlow, "Inhibitors of neurite growth," Annual Review of Neuroscience, vol. 16, pp. 565-595, 1993.
15. V. Pernet and M. E. Schwab, "Lost in the jungle: new hurdles for optic nerve axon regeneration," Trends in Neurosciences, vol. 37, no. 7, pp. 381-387, 2014.
16. A. J. Aguayo, M. Vidal-Sanz, M. P. Villegas-Perez, and G. M. Bray, "Growth and connectivity of axotomized retinal neurons in adult rats with optic nerves substituted by PNS grafts linking the eye and the midbrain," Annals of the New York Academy of Sciences, vol. 495, pp. 1-9, 1987.
17. S. A. Keirstead, M. Vidal-Sanz, M. Rasminsky, A. J. Aguayo, M. Levesque, and K.-F. So, "Responses to light of retinal neurons regenerating axons into peripheral nerve grafts in the rat," Brain Research, vol. 359, no. 1-2, pp. 402-406, 1985.
18. M. Vidal-Sanz, G.M. Bray, M. P. Villegas-Pérez, S. Thanos, and A. J. Aguayo, "Axonal regeneration and synapse formation in the superior colliculus by retinal ganglion cells in the adult rat," Journal of Neuroscience, vol. 7, no. 9, pp. 2894-2909, 1987.
19. L.-P. Cen, J.-M. Luo, Y. Geng, M. Zhang, C. Pui Pang, and Q. Cui, "Long-term survival and axonal regeneration of retinal ganglion cells after optic nerve transection and a peripheral nerve graft," Neuro Report, vol. 23, no. 11, pp. 692-697, 2012.
20. P. D. Smith, F. Sun, K. K. Park et al., "SOCS3 deletion promotes optic nerve regeneration in vivo," Neuron, vol. 64, no. 5, pp. 617-623, 2009.
21. F. Sun, K. K. Park, S. Belin et al., "Sustained axon regeneration induced by co-deletion of PTEN and SOCS3," Nature, vol. 480, no. 7377, pp. 372-375, 2011.
22. K. K. Park, K. Liu, Y. Hu et al., "Promoting axon regeneration in the adult CNS by modulation of the PTEN/mTOR pathway," Science, vol. 322, no. 5903, pp. 963-966, 2008.
23. S. Li, Q. He, H. Wang et al., "Injured adult retinal axons with Pten and Socs3 co-deletion reform active synapses with suprachiasmatic neurons," Neurobiology of Disease, vol. 73, pp. 366-376, 2015.
24. B. J. Yungher, X. Luo, Y. Salgueiro, M. G. Blackmore, and K. K. Park, "Viral vector-based improvement of optic nerve regeneration: characterization of individual axons' growth patterns and synaptogenesis in a visual target," Gene Therapy, 2015.
25. S. de Lima, Y. Koriyama, T. Kurimoto et al., "Full-length axon regeneration in the adultmouse optic nerve and partial recovery of simple visual behaviors," Proceedings of the National Academy of Sciences of the United States of America, vol. 109, no. 23, pp. 9149-9154, 2012.
26. T. Kurimoto, Y. Yin, K. Omura et al., "Long-distance axon regeneration in the mature optic nerve: contributions of oncomodulin, cAMP, and pten gene deletion," The Journal of Neuroscience, vol. 30, no. 46, pp. 15654-15663, 2010.
27. S. Belin, H. Nawabi, C. Wang et al., "Injury-induced decline of intrinsic regenerative ability revealed by quantitative proteomics," Neuron, vol. 86, no. 4, pp. 1000-1014, 2015.
28. N. Aronin and M. DiFiglia, "Huntingtin-lowering strategies in Huntington's disease: antisense oligonucleotides, small RNAs, and gene editing," Movement Disorders, vol. 29, no. 11, pp. 1455-1461, 2014.
29. D. Dalkara and J.-A. Sahel, "Gene therapy for inherited retinal degenerations," Comptes Rendus Biologies, vol. 337, no. 3, pp. 185-192, 2014.
30. M. Chen, Q. Chen, X. Sunet al., "Generationof retinal ganglionlike cells from reprogrammed mouse fibroblasts," Investigative Ophthalmology and Visual Science, vol. 51, no. 11, pp. 5970-5978, 2010.
31. B. Jagatha, M. S. Divya, R. Sanalkumar et al., "In vitro differentiation of retinal ganglion-like cells from embryonic stem cell derived neural progenitors," Biochemical and Biophysical Research Communications, vol. 380, no. 2, pp. 230-235, 2009.
32. S. Parameswaran, S. M. Dravid, P. Teotia et al., "Continuous non-cell autonomous reprogramming to generate retinal ganglion cells for glaucomatous neuropathy," STEM CELLS, vol. 33, no. 6, pp. 1743-1758, 2015.
33. H. Levkovitch-Verbin, O. Sadan, S. Vander et al., "Intravitreal injections of neurotrophic factors secreting mesenchymal stem cells are neuroprotective in rat eyes following optic nerve transaction," Investigative Ophthalmology and Visual Science, vol. 51, no. 12, pp. 6394-6400, 2010.
34. C. Zaverucha-do-Valle, F. Gubert, M. Bargas-Rega et al., "Bone marrow mononuclear cells increase retinal ganglion cell survival and axon regeneration in the adult rat," Cell Transplantation, vol. 20, no. 3, pp. 391-406, 2011.
35. L. A. Mesentier-Louro, C. Zaverucha-do-Valle, A. J. da Silva et al., "Distribution of mesenchymal stem cells and effects on neuronal survival and axon regeneration after optic nerve crush and cell therapy," PLoS ONE, vol. 9, no. 10, Article ID e110722, 2014.
36. P. H. Rosado-De-Castro, P. M. Pimentel-Coelho, L. M. B. da Fonseca, G. R. de Freitas, and R. Mendez-Otero, "The rise of cell therapy trials for stroke: review of published and registered studies," Stem Cells and Development, vol. 22, no. 15, pp. 2095-2111, 2013.
37. R. D. Simari, C. J. Pepine, J. H. Traverse et al., "Bone marrow mononuclear cell therapy for acute myocardial infarction: a perspective from the cardiovascular cell therapy research network," Circulation Research, vol. 114, no. 10, pp. 1564-1568, 2014.
38. C. Pösel, K. Möller, W. Fröhlich, I. Schulz, J. Boltze, and D.-C. Wagner, "Density gradient centrifugation compromises bone marrow mononuclear cell yield," PLoS ONE, vol. 7, no. 12, Article ID e50293, 2012.
39. E. Zhao, H. Xu, L. Wang et al., "Bonemarrow and the control of immunity," Cellular & Molecular Immunology, vol. 9, no. 1, pp. 11-19, 2012.
40. W. W. Pang, E. A. Price, D. Sahoo et al., "Human bone marrow hematopoietic stem cells are increased in frequency and myeloid-biased with age," Proceedings of the National Academy of Sciences of the United States of America, vol. 108, no. 50, pp. 20012-20017, 2011.
41. M. A. Goodell, H. Nguyen, and N. Shroyer, "Somatic stem cell heterogeneity: diversity in the blood, skin and intestinal stem cell compartments," Nature Reviews Molecular Cell Biology, vol. 16, no. 5, pp. 299-309, 2015.
42. T. Asahara, T. Murohara, A. Sullivan et al., "Isolation of putative progenitor endothelial cells for angiogenesis," Science, vol. 275, no. 5302, pp. 964-967, 1997.
43. + regulatory monocytes that inhibit graft-versus-host disease," Science Translational Medicine, vol. 7, no. 281, Article ID 281ra42, 2015.
44. R. J. Berenson, R. G. Andrews, W. I. Bensinger et al., "Antigen CD34+ marrow cells engraft lethally irradiated baboons," Journal of Clinical Investigation, vol. 81, no. 3, pp. 951-955, 1988.
45. Y.-H. Zhao, B. Yuan, J. Chen et al., "Endothelial progenitor cells: therapeutic perspective for ischemic stroke," CNS Neuroscience and Therapeutics, vol. 19, no. 2, pp. 67-75, 2013.
46. K. Stellos, V. Panagiota, A. Kögel, T. Leyhe, M. Gawaz, and C. Laske, "Predictive value of platelet activation for the rate of cognitive decline in Alzheimer's disease patients," Journal of Cerebral Blood Flow & Metabolism, vol. 30, no. 11, pp. 1817-1820, 2010.
47. P. H. Lee, H.-S. Kim, J. E. Lee et al., "Comparison of endothelial progenitor cells in parkinson's disease patients treated with levodopa and levodopa/comt inhibitor," PLoS ONE, vol. 6, no. 6, Article ID e21536, 2011.
48. M. F. Pittenger, A. M. Mackay, S. C. Beck et al., "Multilineage potential of adult human mesenchymal stem cells," Science, vol. 284, no. 5411, pp. 143-147, 1999.
49. A. J. Friedenstein, U. F. Deriglasova, N. N. Kulagina et al., "Precursors for fibroblasts in different populations of hematopoietic cells as detected by the in vitro colony assay method," Experimental Hematology, vol. 2, no. 2, pp. 83-92, 1974.
50. M. Dominici, K. Le Blanc, I. Mueller et al., "Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement," Cytotherapy, vol. 8, no. 4, pp. 315-317, 2006.
51. J. J. Bara, R. G. Richards, M. Alini, and M. J. Stoddart, "Concise review: bone marrow-derived mesenchymal stem cells change phenotype following in vitro culture: implications for basic research and the clinic," Stem Cells, vol. 32, no. 7, pp. 1713-1723, 2014.
52. J. Isern and S. Méndez-Ferrer, "Stem cell interactions in a bone marrow niche," Current Osteoporosis Reports, vol. 9, no. 4, pp. 210-218, 2011.
53. S. Méndez-Ferrer, T. V. Michurina, F. Ferraro et al., "Mesenchymal and haematopoietic stem cells forma unique bone marrow niche," Nature, vol. 466, no. 7308, pp. 829-834, 2010.
54. L. D. S. Meirelles, A. I. Caplan, and N. B. Nardi, "In search of the in vivo identity of mesenchymal stem cells," Stem Cells, vol. 26, no. 9, pp. 2287-2299, 2008.
55. C. M. Kolf, E. Cho, and R. S. Tuan, "Mesenchymal stromal cells. Biology of adult mesenchymal stem cells: regulation of niche, self-renewal and differentiation," Arthritis Research and Therapy, vol. 9, no. 1, article 204, 2007.
56. L. A. Marquez-Curtis, A. Janowska-Wieczorek, L. E. McGann et al., "Cryopreservation of mesenchymal stromal cells derived from various tissues," Cryobiology, vol. 71, no. 2, pp. 181-197, 2015.
57. B. Rüster, S. Göttig, R. J. Ludwig et al., "Mesenchymal stem cells display coordinated rolling and adhesion behavior on endothelial cells," Blood, vol. 108, no. 12, pp. 3938-3944, 2006.
58. A. de Becker, P. van Hummelen, M. Bakkus et al., "Migration of culture-expanded human mesenchymal stem cells through bone marrow endothelium is regulated by matrix metalloproteinase-2 and tissue inhibitor of metalloproteinase-3," Haematologica, vol. 92, no. 4, pp. 440-449, 2007.
59. K. Le Blanc, "Mesenchymal stromal cells: tissue repair and immune modulation," Cytotherapy, vol. 8, no. 6, pp. 559-561, 2006.
60. D. Kyurkchiev, I. Bochev, E. Ivanova-Todorova, and et al, "Secretion of immunoregulatory cytokines by mesenchymal stem cells," World Journal of Stem Cells, vol. 6, no. 5, pp. 552-570, 2014.
61. T. V. Johnson, N. W. Dekorver, V. A. Levasseur et al., "Identification of retinal ganglion cell neuroprotection conferred by platelet-derived growth factor through analysis of the mesenchymal stem cell secretome," Brain, vol. 137, part 2, pp. 503-519, 2014.
62. B. Mead, A. Logan, M. Berry, W. Leadbeater, and B. A. Scheven, "Paracrine-mediated neuroprotection and neuritogenesis of axotomised retinal ganglion cells by human dental pulp stem cells: comparison with human bone marrow and adiposederived mesenchymal stem cells," PLoS ONE, vol. 9, no. 10, Article ID e109305, 2014.
63. L. Moraes, A. Vasconcelos-dos-Santos, F. C. Santana et al., "Neuroprotective effects and magnetic resonance imaging of mesenchymal stem cells labeled with SPION in a rat model of Huntington's disease," Stem Cell Research, vol. 9, no. 2, pp. 143-155, 2012.
64. A. D. V. dos Santos, J. da Costa Reis, B. D. Paredes et al., "Therapeutic window for treatment of cortical ischemia with bone marrow-derived cells in rats," Brain Research, vol. 1306, pp. 149-158, 2010.
65. A. B. Ramos, A. Vasconcelos-Dos-Santos, S. A. L. de Souza et al., "Bone-marrow mononuclear cells reduce neurodegeneration in hippocampal CA1 layer after transient global ischemia in rats," Brain Research, vol. 1522, pp. 1-11, 2013.
66. H. Wan, F. Li, L. Zhu, J. Wang, Z. Yang, and Y. Pan, "Update on therapeutic mechanism for bone marrow stromal cells in ischemic stroke," Journal of Molecular Neuroscience, vol. 52, no. 2, pp. 177-185, 2014.
67. S. Agadi and A. K. Shetty, "Concise review: prospects of bone marrow mononuclear cells and mesenchymal stem cells for treating status epilepticus and chronic epilepsy," Stem Cells, vol. 33, no. 7, pp. 2093-2103, 2015.
68. E. Emre, N. Yüksel, G. Duruksu et al., "Neuroprotective effects of intravitreally transplanted adipose tissue and bone marrow-derived mesenchymal stem cells in an experimental ocular hypertension model," Cytotherapy, vol. 17, no. 5, pp. 543-559, 2015.
69. S. Yu, T. Tanabe, M. Dezawa, H. Ishikawa, and N. Yoshimura, "Effects of bone marrow stromal cell injection in an experimental glaucoma model," Biochemical and Biophysical Research Communications, vol. 344, no. 4, pp. 1071-1079, 2006.
70. M. M. Harper, S. D. Grozdanic, B. Blits et al., "Transplantation of BDNF-secreting mesenchymal stem cells provides neuroprotection in chronically hypertensive rat eyes," Investigative Ophthalmology & Visual Science, vol. 52, no. 7, pp. 4506-4515, 2011.
71. T. V. Johnson, N. D. Bull, D. P. Hunt, N. Marina, S. I. Tomarev, and K. R. Martin, "Neuroprotective effects of intravitreal mesenchymal stem cell transplantation in experimental glaucoma," Investigative Ophthalmologyand Visual Science, vol. 51, no. 4, pp. 2051-2059, 2010.
72. N. Li, X. R. Li, and J. Q. Yuan, "Effects of bone-marrow mesenchymal stem cells transplanted into vitreous cavity of rat injured by ischemia/reperfusion," Graefe's Archive for Clinical and Experimental Ophthalmology, vol. 247, no. 4, pp. 503-514, 2009.
73. Y. Hu, H. B. Tan, X. M. Wang, H. Rong, H. P. Cui, and H. Cui, "Bone marrow mesenchymal stem cells protect against retinal ganglion cell loss in aged rats with glaucoma," Clinical Interventions in Aging, vol. 8, pp. 1467-1470, 2013.
74. R. Manuguerra-Gagné, P. R. Boulos, A. Ammar et al., "Transplantation of mesenchymal stem cells promotes tissue regeneration in a glaucoma model through laser-induced paracrine factor secretion and progenitor cell recruitment," Stem Cells, vol. 31, no. 6, pp. 1136-1148, 2013.
75. L. A. Mesentier-Louro, J. Coronel, C. Zaverucha-do-Valle et al., "Cell therapy modulates expression of Tax1-binding protein 1 and synaptotagmin IV in a model of optic nerve lesion," Investigative Ophthalmology and Visual Science, vol. 53, no. 8, pp. 4720-4729, 2012.
76. C. Zaverucha-do-Valle, L. Mesentier-Louro, F. Gubert et al., "Sustained effect of bone marrow mononuclear cell therapy in axonal regeneration in a model of optic nerve crush," Brain Research, vol. 1587, no. 1, pp. 54-68, 2014.
77. H. B. Tan, X. Kang, S. H. Lu, and L. Liu, "The therapeutic effects of bone marrow mesenchymal stem cells after optic nerve damage in the adult rat," Clinical Interventions in Aging, vol. 10, pp. 487-490, 2015.
78. T. Zhao, Y. Li, L. Tang, Y. Li, F. Fan, and B. Jiang, "Protective effects of human umbilical cord blood stem cell intravitreal transplantation against optic nerve injury in rats," Graefe's Archive for Clinical and Experimental Ophthalmology, vol. 249, no. 7, pp. 1021-1028, 2011.
79. B. Jiang, P. Zhang, D. Zhou, J. Zhang, X. Xu, and L. Tang, "Intravitreal transplantation of human umbilical cord blood stem cells protects rats from traumatic optic neuropathy," PLoS ONE, vol. 8, no. 8, Article ID e69938, 2013.
80. M. Chen, Z. Xiang, and J. Cai, "The anti-apoptotic and neuroprotective effects of human umbilical cord blood mesenchymal stem cells (hUCB-MSCs) on acute optic nerve injury is transient," Brain Research, vol. 1532, pp. 63-75, 2013.
81. low monocytes monitor endothelial cells and orchestrate their disposal," Cell, vol. 153, no. 2, pp. 362-375, 2013.
82. F. Ginhoux and S. Jung, "Monocytes and macrophages: developmental pathways and tissue homeostasis," Nature Reviews Immunology, vol. 14, no. 6, pp. 392-404, 2014.
83. A. London, E. Itskovich, I. Benhar et al., "Neuroprotection and progenitor cell renewal in the injured adult murine retina requires healing monocyte-derived macrophages," The Journal of Experimental Medicine, vol. 208, no. 1, pp. 23-39, 2011.
84. T. F. Yuan, Y. X. Liang, B. Peng, B. Lin, and K. So, "Local proliferation is the main source of rod microglia after optic nerve transection," Scientific Reports, vol. 5, Article ID 10788, 2015.
85. S. Leon, Y. Yin, J. Nguyen, N. Irwin, and L. I. Benowitz, "Lens injury stimulates axon regeneration in the mature rat optic nerve," Journal of Neuroscience, vol. 20, no. 12, pp. 4615-4626, 2000.
86. T. Kurimoto, Y. Yin, G. Habboub et al., "Neutrophils express oncomodulin and promote optic nerve regeneration," The Journal of Neuroscience, vol. 33, no. 37, pp. 14816-14824, 2013.
87. Y. Yin, Q. Cui, H.-Y. Gilbert et al., "Oncomodulin links inflammation to optic nerve regeneration," Proceedings of the National Academy of Sciences of the United States of America, vol. 106, no. 46, pp. 19587-19592, 2009.
88. Y. Huang, Z. Li, N. van Rooijen, N. Wang, C. P. Pang, and Q. Cui, "Different responses of macrophages in retinal ganglion cell survival after acute ocular hypertension in rats with different autoimmune backgrounds," Experimental Eye Research, vol. 85, no. 5, pp. 659-666, 2007.
89. I. N. Shalova, J. Y. Lim, M. Chittezhath et al., "Human monocytes undergo functional re-programming during sepsis mediated by hypoxia-inducible factor-1α," Immunity, vol. 42, no. 3, pp. 484-498, 2015.
90. A. Yanai, U. O. Häfeli, A. L. Metcalfe et al., "Focused magnetic stem cell targeting to the retina using superparamagnetic iron oxide nanoparticles," Cell Transplantation, vol. 21, no. 6, pp. 1137-1148, 2012.
91. T. V. Johnson, N. D. Bull, and K. R. Martin, "Identification of barriers to retinal engraftment of transplanted stem cells," Investigative Ophthalmology and Visual Science, vol. 51, no. 2, pp. 960-970, 2010.
92. P. Castanheira, L. Torquetti, M. B. Nehemy, and A. M. Goes, "Retinal incorporation and differentiation of mesenchymal stem cells intravitreally injected in the injured retina of rats," Arquivos Brasileiros de Oftalmologia, vol. 71, no. 5, pp. 644-650, 2008.
93. P. Castanheira, L. T. Torquetti, D. R. S. Magalhãs, M. B. Nehemy, and A. M. Goes, "DAPI diffusion after intravitreal injection of mesenchymal stem cells in the injured retina of rats," Cell Transplantation, vol. 18, no. 4, pp. 423-431, 2009.
94. M. S. Singh and R. E. MacLaren, "Stem cells as a therapeutic tool for the blind: biology and future prospects," Proceedings of the Royal Society B: Biological Sciences, vol. 278, no. 1721, pp. 3009-3016, 2011.
95. P. A. Keane and S. R. Sadda, "Retinal imaging in the twenty-first century," Ophthalmology, vol. 121, no. 12, pp. 2489-2500, 2014.
96. A. S. Arbab, B. Janic, J. Haller, E. Pawelczyk, W. Liu, and J. A. Frank, "In vivo cellular imaging for translational medical research," Current Medical Imaging Reviews, vol. 5, no. 1, pp. 19-38, 2009.
97. M. D. Fischer, T. Goldmann, C. Wallrapp et al., "Successful subretinal delivery and monitoring of Micro Beads in mice," PLoS ONE, vol. 8, no. 1, Article ID e55173, 2013.
98. T.W. Corson, B. C. Samuels, A. A. Wenzel et al., "Multimodality imaging methods for assessing retinoblastoma orthotopic xenograft growth and development," PLoS ONE, vol. 9, no. 6, Article ID e99036, 2014.
99. S. S. Yaghoubi, D. O. Campbell, C. G. Radu, and J. Czernin, "Positron emission tomography reporter genes and reporter probes: gene and cell therapy applications," Theranostics, vol. 2, no. 4, pp. 374-391, 2012.
100. D. L. Kraitchman and J. W. M. Bulte, "Imaging of stem cells using MRI," Basic Research in Cardiology, vol. 103, no. 2, pp. 105-113, 2008.
101. C. J. Palestro, C. Love, and K. K. Bhargava, "Labeled leukocyte imaging: current status and future directions," Quarterly Journal of Nuclear Medicine and Molecular Imaging, vol. 53, no. 1, pp. 105-123, 2009.
102. G. Mariani, L. Bruselli, T. Kuwert et al., "A review on the clinical uses of SPECT/CT," European Journal of Nuclear Medicine and Molecular Imaging, vol. 37, no. 10, pp. 1959-1985, 2010.
103. A. Bockisch, L. S. Freudenberg, D. Schmidt, and T. Kuwert, "Hybrid imaging by SPECT/CTand PET/CT: proven outcomes in cancer imaging," Seminars in Nuclear Medicine, vol. 39, no. 4, pp. 276-289, 2009.
104. D. L. Kraitchman, W. D. Gilson, and C. H. Lorenz, "Stem cell therapy: MRI guidance and monitoring," Journal of Magnetic Resonance Imaging, vol. 27, no. 2, pp. 299-310, 2008.
105. A. Haddad-Mashadrizeh, A. R. Bahrami, M. M. Matin et al., "Human adipose-derived mesenchymal stem cells can survive and integrate into the adult rat eye following xenotransplantation," Xenotransplantation, vol. 20, no. 3, pp. 165-176, 2013.
106. B. Mead, A. Logan, M. Berry, W. Leadbeater, and B. A. Scheven, "Intravitreally transplanted dental pulp stem cells promote neuroprotection and axon regeneration of retinal ganglion cells after optic nerve injury," Investigative Ophthalmology and Visual Science, vol. 54, no. 12, pp. 7544-7556, 2013.
107. M. Fiedorowicz, W. Dyda, R. Rejdak, and P. Grieb, "Magnetic resonance in studies of glaucoma," Medical Science Monitor, vol. 17, no. 10, pp. RA227-RA232, 2011.
108. R. Haenold, K.-H. Herrmann, S. Schmidt et al., "Magnetic resonance imaging of the mouse visual pathway for in vivo studies of degeneration and regeneration in the CNS," Neuro Image, vol. 59, no. 1, pp. 363-376, 2012.
109. 2," Magnetic Resonance in Medicine, vol. 48, no. 5, pp. 852-859, 2002.
110. B. A. Berkowitz, R. Roberts, H. Luan et al., "Manganeseenhanced MRI studies of alterations of intraretinal ion demand in models of ocular injury," Investigative Ophthalmology and Visual Science, vol. 48, no. 8, pp. 3796-3804, 2007.
111. S. Boretius, I. Gadjanski, I. Demmer et al., "MRI of optic neuritis in a rat model," Neuro Image, vol. 41, no. 2, pp. 323-334, 2008.
112. R. G. Pautler and A. P. Koretsky, "Tracing odor-induced activation in the olfactory bulbs of mice using manganese-enhanced magnetic resonance imaging," Neuro Image, vol. 16, no. 2, pp. 441-448, 2002.
113. 2+," Journal of Magnetic Resonance Imaging, vol. 28, no. 4, pp. 855-865, 2008.
114. 2+ significantly impairs mouse visual acuity: a comparison with intravitreal injection," NMR in Biomedicine, vol. 27, no. 4, pp. 390-398, 2014.
115. A. Kretz, C. J. Happold, J. K. Marticke, and S. Isenmann, "Erythropoietin promotes regeneration of adult CNS neurons via Jak2/Stat3 and PI3K/AKT pathway activation," Molecular and Cellular Neuroscience, vol. 29, no. 4, pp. 569-579, 2005.
116. F. C. Mansergh, N. Chadderton, P. F. Kenna, O. L. Gobbo, and G. J. Farrar, "Cell therapy using retinal progenitor cells shows therapeutic effect in a chemically-induced rotenone mouse model of Leber hereditary optic neuropathy," European Journal of Human Genetics, vol. 22, no. 11, pp. 1314-1320, 2014.
117. J. Crossgrove and W. Zheng, "Manganese toxicity upon overexposure," NMR in Biomedicine, vol. 17, no. 8, pp. 544-553, 2004.
118. X. Zhang, P. Sun, J. Wang, Q. Wang, and S.-K. Song, "Diffusion tensor imaging detects retinal ganglion cell axon damage in the mousemodel of optic nerve crush," Investigative Ophthalmology and Visual Science, vol. 52, no. 9, pp. 7001-7006, 2011.
119. 2+- enhanced and diffusion tensor MR imaging gives complementary information about injury and regeneration in the adult rat optic nerve," Journal of Magnetic Resonance Imaging, vol. 29, no. 1, pp. 39-51, 2009.
120. S. L. Grillo and P. Koulen, "Psychophysical testing in rodent models of glaucomatous optic neuropathy," Experimental Eye Research, 2015.
121. B. Young, E. Eggenberger, and D. Kaufman, "Current electrophysiology in ophthalmology: a review," Current Opinion in Ophthalmology, vol. 23, no. 6, pp. 497-505, 2012.
122. Z.-J. Zhang, Y.-J. Li, X.-G. Liu et al., "Human umbilical cord blood stem cells and brain-derived neurotrophic factor for optic nerve injury: a biomechanical evaluation," Neural Regeneration Research, vol. 10, no. 7, p. 1134, 2015.
123. I. B. Black and D. Woodbury, "Adult rat and human bone marrow stromal stem cells differentiate into neurons," Blood Cells, Molecules, and Diseases, vol. 27, no. 3, pp. 632-636, 2001.
124. W. Deng, M. Obrocka, I. Fischer, and D. J. Prockop, "In vitro differentiation of human marrow stromal cells into early progenitors of neural cells by conditions that increase intracellular cyclic AMP," Biochemical and Biophysical Research Communications, vol. 282, no. 1, pp. 148-152, 2001.
125. G. Muñoz-Elias, D. Woodbury, and I. B. Black, "Marrow stromal cells, mitosis, and neuronal differentiation: stem cell and precursor functions," Stem Cells, vol. 21, no. 4, pp. 437-448, 2003.
126. D. Woodbury, E. J. Schwarz, D. J. Prockop, and I. B. Black, "Adult rat and human bone marrow stromal cells differentiate into neurons," Journal of Neuroscience Research, vol. 61, no. 4, pp. 364-370, 2000.
127. M. Alvarez-Dolado, R. Pardal, J. M. Garcia-Verdugo et al., "Fusion of bone-marrow-derived cells with Purkinje neurons, cardiomyocytes and hepatocytes," Nature, vol. 425, no. 6961, pp. 968-973, 2003.
128. A. M. Parr, C.H. Tator, and A. Keating, "Bonemarrow-derived mesenchymal stromal cells for the repair of central nervous system injury," Bone Marrow Transplantation, vol. 40, no. 7, pp. 609-619, 2007.
129. N. Terada, T. Hamazaki, M. Oka et al., "Bonemarrowcells adopt the phenotype of other cells by spontaneous cell fusion," Nature, vol. 416, no. 6880, pp. 542-545, 2002.
130. A. Uccelli, L. Moretta, and V. Pistoia, "Mesenchymal stem cells in health and disease," Nature Reviews Immunology, vol. 8, no. 9, pp. 726-736, 2008.
131. N. Nakano, Y. Nakai, T.-B. Seo et al., "Characterization of conditioned medium of cultured bone marrow stromal cells," Neuroscience Letters, vol. 483, no. 1, pp. 57-61, 2010.
132. A. Tassoni, A. Gutteridge, A. C. Barber, A. Osborne, and K. R. Martin, "Molecular mechanisms mediating retinal reactive gliosis following bone marrow mesenchymal stem cell (BMMSC) transplantation," Stem Cells, 2015.
133. G. M. Spaggiari and L. Moretta, "Cellular and molecular interactions of mesenchymal stem cells in innate immunity," Immunology and Cell Biology, vol. 91, no. 1, pp. 27-31, 2013.
134. G. Raicevic, R. Rouas, M. Najar et al., "Inflammation modifies the pattern and the function of Toll-like receptors expressed by human mesenchymal stromal cells," Human Immunology, vol. 71, no. 3, pp. 235-244, 2010.
135. R. S. Waterman, S. L. Tomchuck, S. L. Henkle, and A. M. Betancourt, "A new mesenchymal stem cell (MSC) paradigm: polarization into a pro-inflammatory MSC1 or an immunosuppressive MSC2 phenotype," PLoS ONE, vol. 5, no. 4, Article ID e10088, 2010.
136. T. Katsuda, N. Kosaka, F. Takeshita, and T. Ochiya, "The therapeutic potential ofmesenchymal stem cell-derived extracellular vesicles," Proteomics, vol. 13, no. 10-11, pp. 1637-1653, 2013.
137. D. Giunti, B. Parodi, C. Usai et al., "Mesenchymal stem cells shape microglia effector functions through the release of CX3CL1," Stem Cells, vol. 30, no. 9, pp. 2044-2053, 2012.
138. D. Drago, C. Cossetti, N. Iraci et al., "The stem cell secretome and its role in brain repair," Biochimie, vol. 95, no. 12, pp. 2271-2285, 2013.
139. H. Xin, Y. Li, Z. Liu et al., "miR-133b promotes neural plasticity and functional recovery after treatment of stroke with multipotent mesenchymal stromal cells in rats via transfer of exosomeenriched extracellular particles," Stem Cells, vol. 31, no. 12, pp. 2737-2746, 2013.
140. J. B. Jonas, M. Witzens-Harig, L. Arseniev, and A. D. Ho, "Intravitreal autologous bone marrow-derived mononuclear cell transplantation: a feasibility report," Acta ophthalmologica, vol. 86, no. 2, pp. 225-226, 2008.
141. P. Connick, M. Kolappan, C. Crawley et al., "Autologous mesenchymal stem cells for the treatment of secondary progressive multiple sclerosis: an open-label phase 2a proof-of-concept study," The Lancet Neurology, vol. 11, no. 2, pp. 150-156, 2012.
142. B. Mead, M. Berry, A. Logan, R. A. Scott, W. Leadbeater, and B. A. Scheven, "Stem cell treatment of degenerative eye disease," Stem Cell Research, vol. 14, no. 3, pp. 243-257, 2015.